Covestor LTD Baxter International Inc Transaction History

Covestor LTD

$160 Million
Q4 2024

A detailed history of Covestor LTD transactions in Baxter International Inc stock. As of the latest transaction made, Covestor LTD holds 5,953 shares of BAX stock, worth $201,330. This represents 0.11% of its overall portfolio holdings.

Number of Shares

5,953

Previous 6,431 7.43%

Holding current value

$201,330

Previous $244,000 28.69%

% of portfolio

0.11%

Previous 0.15%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$28.63 - $37.84 $13,685 - $18,087	-478 Reduced 7.43%	5,953 $174,000
Q3 2024 Nov 01, 2024	BUY	$32.85 - $40.26 $40,044 - $49,076	1,219 Added 23.39%	6,431 $244,000
Q2 2024 Aug 09, 2024	SELL	$32.87 - $43.55 $48,121 - $63,757	-1,464 Reduced 21.93%	5,212 $175,000
Q1 2024 May 10, 2024	BUY	$37.88 - $43.77 $74,926 - $86,577	1,978 Added 42.1%	6,676 $286,000
Q4 2023 Feb 09, 2024	BUY	$31.71 - $38.95 $74,550 - $91,571	2,351 Added 100.17%	4,698 $182,000
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $11,905 - $15,723	-319 Reduced 11.97%	2,347 $89,000
Q2 2023 Aug 11, 2023	SELL	$39.98 - $47.68 $19,750 - $23,553	-494 Reduced 15.63%	2,666 $121,000
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $24,088 - $33,697	641 Added 25.45%	3,160 $128,000
Q4 2022 Feb 13, 2023	BUY	$49.7 - $57.71 $11,679 - $13,561	235 Added 10.29%	2,519 $128,000
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $37,432 - $46,426	695 Added 43.74%	2,284 $123,000
Q2 2022 Aug 10, 2022	SELL	$63.83 - $80.0 $41,234 - $51,680	-646 Reduced 28.9%	1,589 $102,000
Q1 2022 May 13, 2022	BUY	$76.85 - $89.45 $79,770 - $92,849	1,038 Added 86.72%	2,235 $173,000
Q4 2021 Feb 10, 2022	BUY	$74.57 - $87.19 $89,260 - $104,366	1,197 New	1,197 $103,000

Others Institutions Holding BAX

# of Institutions

938

Shares Held

468M

Call Options Held

2.57M

Put Options Held

3.29M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account